Latest news with #MarketInsights
Yahoo
05-06-2025
- Business
- Yahoo
Ivans Index May 2025 Results Released
Renewal rates for all major commercial lines of business, except Workers' Compensation remain up year over year; rate change variable month over month Milwaukee, WI., June 05, 2025 (GLOBE NEWSWIRE) -- Ivans® today announced the May 2025 results of the Ivans Index™, the insurance industry's premium renewal rate index. Year over year, Commercial Auto, BOP, General Liability, Commercial Property and Umbrella experienced increasing average premium renewal rates, while premium renewal rates decreased for Workers' Compensation. Month over month, Commercial Auto, General Liability, and Commercial Property experienced increases in premium renewal rate change, while BOP, Umbrella, and Workers' Compensation saw a renewal rate change by line of business for May 2025 highlights include: Commercial Auto: 8.45%, up slightly from 8.41% last month. BOP: 7.89%, down slightly from 7.98% at the end of April. General Liability: 4.86%, up from April, which was 4.33%. Commercial Property: 7.77%, up slightly from 7.70% in April. Umbrella: 9.11%, down from 9.41% in April. Workers' Compensation: -1.87%, down from -1.78% last month. Released monthly, Ivans Index is a data-driven report of current conditions and trends for premium rate renewal change of the most placed commercial lines of business in the insurance industry. Analyzing more than 120 million data transactions, the Ivans Index premium renewal rate change measures the premium difference year over year for a single consistent policy. Inclusive of more than 38,000 agencies and 700 carriers and MGAs, the Ivans Index is reflective of the premium rate change trends being experienced by all agencies and insurers across the U.S. insurance market. Ivans Index is available to agencies and insurers as part of Market Insights at Download the complete Q1 2025 Ivans Index report. # # # The Ivans logos are trademarks of Applied Systems, Inc., registered in the IvansIvans is where insurance carriers, agents, and MGAs come together to grow their businesses. Every day, our 38,000 agents and over 700 carrier and MGA partners plug into technology that empowers them to better determine appetite and eligibility, swiftly produce quotes, get accurate claims and commission updates, automatically communicate policy data, and connect to one another to drive new business. With easier ways to get the day's work done, insurance professionals can open the door to more revenue without letting complexity in behind it. CONTACT: Lauren Malcolm Ivans 678-438-5093 lmalcolm@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
27-05-2025
- Business
- Yahoo
Energy Transition Update - Norway's Renewable Energy Policies Revealed Key Insights
The "Norway Renewable Energy Policy Handbook 2025" report provides comprehensive insights into Norway's legislative and strategic frameworks for promoting renewable energy. It outlines the policy measures and incentives implemented at both national and regional levels, detailing specific targets, plans, and frameworks designed to enhance renewable energy development. The handbook highlights various renewable energy technologies, including their growth potential within the country, and discusses opportunities and challenges in leveraging these technologies. Readers can utilize this information to support strategic decision-making, remain informed about policy changes, and compare levels of support provided to different renewable technologies across Norway. In other market news, was a standout up 10% and ending the day at ₹2,072.70. In the meantime, softened, down 3.6% to finish the session at CN¥83.30. Act fast as GE Vernova T&D India's expansion into export markets can bolster revenue; click here to explore the detailed narrative on the company's potential. You may want to read our Market Insights article titled "Automakers Caught In The Tariff Crossfire," where we explored how unpredictable tariffs impact automakers' investment in electric vehicles—dive in before the market shifts again. settled at $158.38 up 1.3%. settled at $136.54 up 0.9%, close to the 52-week low. ended the day at $339.34 down 0.5%. Click through to start exploring the rest of the 150 Energy Transition Stocks including JSW Energy, Southern and Industrias Peñoles. de now. Ready To Venture Into Other Investment Styles? This technology could replace computers: discover the 22 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sources: Simply Wall St "Norway Renewable Energy Policy Handbook 2025: Understand Targets, Frameworks, and Technology-specific Incentives" from Research and Markets on GlobeNewswire (published 23 May 2025) Companies discussed in this article include BSE:522275 NasdaqGS:FSLR NYSE:CVX NasdaqGS:TSLA and SHSE:605117. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
21-05-2025
- Business
- Yahoo
Global AI in Diagnostics Market to Register Stunning Growth at a CAGR of ~22% by 2032
The increasing incidence of infectious and chronic illnesses is boosting the need for early and precise diagnosis, with AI playing a crucial role by improving detection and enabling quicker clinical decisions. At the same time, the widespread adoption of digital health and imaging technologies creates a solid base for integrating AI into current healthcare systems, enhancing both efficiency and accuracy. Furthermore, ongoing product innovation by major global players, driven by progress in machine learning and growing regulatory backing, is accelerating the availability of AI-based diagnostic solutions. New York, USA, May 21, 2025 (GLOBE NEWSWIRE) -- Global AI in Diagnostics Market to Register Stunning Growth at a CAGR of ~22% by 2032 | DelveInsight The increasing incidence of infectious and chronic illnesses is boosting the need for early and precise diagnosis, with AI playing a crucial role by improving detection and enabling quicker clinical decisions. At the same time, the widespread adoption of digital health and imaging technologies creates a solid base for integrating AI into current healthcare systems, enhancing both efficiency and accuracy. Furthermore, ongoing product innovation by major global players, driven by progress in machine learning and growing regulatory backing, is accelerating the availability of AI-based diagnostic solutions. DelveInsight's AI in Diagnostics Market Insights report provides the current and forecast market analysis, individual leading AI in diagnostics companies' market shares, challenges, AI in diagnostics market drivers, barriers, trends, and key market AI in diagnostics companies in the market. Key Takeaways from the AI in Diagnostics Market Report As per DelveInsight estimates, North America is anticipated to dominate the global AI in diagnostics market during the forecast period. In the component segment of the AI in diagnostics market, the software category captured a significant revenue share in 2024. Notable AI in diagnostics companies such as Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, and several others are currently operating in the AI in diagnostics market. In September 2024, Ibex Medical Analytics (Ibex), a leader in AI-powered cancer diagnostics, introduced the latest advancements in its innovative product platform, Ibex-AI. These new features, developed in collaboration with expert pathologists worldwide who actively use the platform in routine clinical practice, highlight Ibex's ongoing commitment to creating cutting-edge diagnostic tools tailored to the needs of healthcare professionals on the frontlines of patient care. In October 2023, Lucida Medical Ltd announced that it received Class IIb CE certification for its AI-powered prostate cancer detection software, Prostate IntelligenceTM (PiTM). Leveraging advanced AI technology, PiTM analyzes MRI scans and is seamlessly integrated into the radiologist's workflow. In March 2023, Qritive launched its latest AI-driven innovation, QAi Prostate, designed specifically for prostate cancer diagnosis. Utilizing cutting-edge machine learning algorithms, QAi Prostate analyzes whole slide images of prostate core needle biopsies with high precision. To read more about the latest highlights related to the AI in diagnostics market, get a snapshot of the key highlights entailed in the Global AI in Diagnostics Market Report AI in Diagnostics Overview Artificial Intelligence (AI) is revolutionizing diagnostics by enabling faster, more accurate detection of diseases through advanced data analysis and pattern recognition. AI-powered systems can analyze medical images such as X-rays, MRIs, and CT scans with high precision, often matching or exceeding the performance of human radiologists in identifying abnormalities like tumors, fractures, or infections. By processing vast amounts of data from electronic health records, lab results, and genomics, AI algorithms can also uncover hidden correlations, assist in early disease prediction, and support personalized treatment plans. Moreover, AI is streamlining workflows in diagnostic laboratories and reducing the burden on healthcare professionals. For instance, AI-driven tools can automate routine tasks such as blood sample analysis or pathology slide interpretation, allowing clinicians to focus on complex cases. In resource-constrained settings, AI has the potential to bridge the gap in healthcare access by providing decision support to less experienced practitioners. As AI continues to evolve, integrating real-time data and improving interpretability, it holds the promise of significantly enhancing diagnostic accuracy, speed, and overall patient in Diagnostics Market Insights North America is expected to dominate the overall Artificial Intelligence (AI) in Diagnostics market over the forecast period, driven by advanced healthcare infrastructure, significant investments in AI technologies, and widespread adoption of digital health solutions. The United States, in particular, leads the region due to its early adoption of cutting-edge technologies, strong presence of leading AI and healthcare companies, and supportive regulatory frameworks. The growing demand for early and accurate diagnosis, especially for chronic and complex diseases such as cancer and cardiovascular conditions, has propelled the integration of AI into diagnostic tools and platforms. Major healthcare institutions in the region are increasingly leveraging AI algorithms for imaging analysis, pathology, and predictive diagnostics, further accelerating market growth. Moreover, robust government initiatives and funding programs supporting AI research in healthcare continue to fuel innovation and development. Strategic collaborations between technology firms and medical institutions are resulting in AI solutions with improved accuracy and efficiency, contributing to enhanced patient outcomes. The presence of a tech-savvy population, favorable reimbursement policies for AI-enabled diagnostic procedures, and a well-established ecosystem of data-driven healthcare systems also contribute to North America's leading position in this domain. As AI technologies mature and gain greater clinical acceptance, the region is expected to remain at the forefront of global advancements in AI-driven diagnostics. To know more about why North America is leading the market growth in the AI in diagnostics market, get a snapshot of the AI in Diagnostics Market Outlook AI in Diagnostics Market Dynamics The AI in diagnostics market has seen significant growth due to technological advancements in machine learning (ML) and artificial intelligence (AI), allowing for the automation and enhancement of diagnostic processes. AI-powered diagnostic tools are revolutionizing areas such as imaging, pathology, and molecular diagnostics, enabling faster, more accurate results with reduced human error. This has become especially crucial in areas like cancer detection, where early identification can significantly impact treatment outcomes. AI algorithms, capable of analyzing vast datasets, can detect patterns and abnormalities in medical imaging that may be missed by the human eye, leading to earlier intervention. The market dynamics are also being influenced by the increasing demand for personalized healthcare. As healthcare systems move towards precision medicine, AI in diagnostics plays a vital role by tailoring diagnostic tests and treatments based on individual genetic profiles. This is particularly significant in oncology, where molecular diagnostics are being enhanced by AI to offer more targeted therapeutic options. With this move toward personalized diagnostics, the role of AI in predicting disease outcomes and treatment responses continues to expand, driving the need for more sophisticated diagnostic tools. Furthermore, regulatory approvals and integration with healthcare systems are key to AI's success in diagnostics. Governments and healthcare bodies are gradually developing guidelines for AI in clinical settings, which is boosting investor confidence and enabling more widespread adoption. However, challenges such as data privacy concerns, interoperability issues, and the need for large-scale validation studies still pose barriers to the full-scale integration of AI diagnostics. As a result, partnerships between AI companies and traditional diagnostic firms are becoming more common to combine the strengths of AI technologies with the reliability and credibility of established healthcare systems. The growing prevalence of chronic diseases and the increasing burden on healthcare systems globally are also driving the adoption of AI in diagnostics. AI can assist in managing large patient populations by streamlining workflows, reducing diagnostic errors, and providing healthcare professionals with better decision-making tools. The market is also seeing the emergence of AI-driven platforms that offer end-to-end diagnostic solutions, from initial patient consultation to final diagnosis, creating a more seamless healthcare experience. As AI technologies continue to mature, the market is expected to experience even greater expansion, making healthcare more accessible, efficient, and accurate. Get a sneak peek at the AI in diagnostics market dynamics @ AI in Diagnostics Market Dynamic Analysis Report Metrics Details Coverage Global Study Period 2022–2032 AI in Diagnostics Market CAGR ~22% AI in Diagnostics Market Size by 2032 USD 8 Billion Key AI in Diagnostics Companies Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, among others AI in Diagnostics Market Assessment AI in Diagnostics Market Segmentation AI in Diagnostics Market Segmentation By Component: Hardware/software, and Services AI in Diagnostics Market Segmentation By Application: Infectious Disease Diagnostics, Radiology, Oncology, Cardiology, and Others AI in Diagnostics Market Segmentation By Technology: Machine Learning, Natural Language Processing, and Others AI in Diagnostics Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View Which MedTech key players in the AI in diagnostics market are set to emerge as the trendsetter explore @ AI in Diagnostics Companies Table of Contents 1 AI in Diagnostics Market Report Introduction 2 AI in Diagnostics Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 AI in Diagnostics Market Key Factors Analysis 6 AI in Diagnostics Market Porter's Five Forces Analysis 7 AI in Diagnostics Market Layout 8 AI in Diagnostics Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us Interested in knowing the AI in diagnostics market by 2032? Click to get a snapshot of the AI in Diagnostics Market Trends Related Reports AI in Cancer Diagnostics Market AI in Cancer Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in cancer diagnostics companies, including iCAD, Inc., ibex-ai, Roche Diagnostics, Kheiron Medical Technologies Limited, MVision AI Inc., Siemens Healthineers AG, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., IBM Corporation, Azra AI, ConcertAI, PathAI, Median Technologies, Paige AI Inc., Therapixel, Flatiron, Freenome Holdings Inc., Sonrai Analytics, among others. Artificial Intelligence In Clinical Trials Market Artificial Intelligence In Clinical Trials Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in clinical trials companies, including TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, among others. Artificial Intelligence In Drug Discovery Market Artificial Intelligence In Drug Discovery Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in drug discovery companies, including IBM Corporation, Numedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals Inc, Alphabet Inc (DeepMind), Insilico Medicine, BenevolentAI, Exscientia, Cyclia, Valo Health, Owkin Inc, Verge Genomics, BioSymetrics, among others. Artificial Intelligence in Drug Commercialization Market Artificial Intelligence in Drug Commercialization Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in drug commercialization companies, including EVERSANA, Lyfegen, Syneos Health, McKinsey & Company, ICON plc., Clarivate., Thermo Fisher Scientific Inc., Viseven, ZS Associates, Cloud Pharmaceuticals Inc., among others. Artificial Intelligence in Precision Medicine Market Artificial Intelligence in Precision Medicine Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in precision medicine companies, including TEMPUS, GE HealthCare, Envisionit Deep AI (Pty) Ltd., Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., among others. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. CONTACT: Contact Us Shruti Thakur info@ +14699457679
Yahoo
20-05-2025
- Automotive
- Yahoo
Electric Vehicles Today - Charging Connectivity: Powering The Future Of Transportation
The Electric Vehicle Charging System Connectivity Market is experiencing rapid growth due to increasing EV adoption, the expansion of charging infrastructure, and advancements in smart grid integration. This market is driven by the evolution of smart and connected chargers and government incentives to boost EV infrastructure. Emerging technologies like LTE-M and 5G are pivotal, allowing for remote monitoring, predictive maintenance, and seamless payment integration, which enhance user experience and grid stability. Integration with vehicle-to-grid connectivity and smart grids, alongside challenges such as implementation costs and standardization issues, play significant roles in shaping the future of EV charging efficiency and interoperability. In other trading, was a notable mover up 4.7% and ending the day at ¥356. At the same time, lagged, down 5.7% to end the day at €77.58. On Wednesday, the company held its Annual General Meeting. Nissan's focus on new energy vehicles amid restructuring offers timely potential opportunities. Click here to explore Nissan's strategic initiatives further. Don't miss our Market Insights article on automation and robotics, where we explored how AI-powered autonomous vehicles are reshaping transportation; dive in now before the trend accelerates further! ended the day at HK$434.20 up 3.3%, near its 52-week high. closed at $10.75 up 0.9%. On Monday, key proposals regarding a collective bargaining policy and supply chain emissions report were not approved at the company's annual shareholder meeting. finished trading at $342.82 down 1.4%. Dive into all 54 of the EV Stocks we have identified, like Honda Motor, Chongqing Qianli Technology and Gentex, right here. Curious About Other Options? We've found 15 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sources: Simply Wall St "Electric Vehicle Charging System Connectivity Market Report 2025-2035: Increasing Demand for Smart and Connected Chargers, Evolution of LTE-M and Its Role in the Future of EV Chargers" from Research and Markets on GlobeNewswire (published 15 May 2025) Companies discussed in this article include TSE:7201 SEHK:1211 NYSE:F NasdaqGS:TSLA and XTRA:BMW. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16-05-2025
- Automotive
- Yahoo
Electric Vehicles Today - Charging Connectivity: Powering The Future Of Transportation
The Electric Vehicle Charging System Connectivity Market is experiencing rapid growth due to increasing EV adoption, the expansion of charging infrastructure, and advancements in smart grid integration. This market is driven by the evolution of smart and connected chargers and government incentives to boost EV infrastructure. Emerging technologies like LTE-M and 5G are pivotal, allowing for remote monitoring, predictive maintenance, and seamless payment integration, which enhance user experience and grid stability. Integration with vehicle-to-grid connectivity and smart grids, alongside challenges such as implementation costs and standardization issues, play significant roles in shaping the future of EV charging efficiency and interoperability. In other trading, was a notable mover up 4.7% and ending the day at ¥356. At the same time, lagged, down 5.7% to end the day at €77.58. On Wednesday, the company held its Annual General Meeting. Nissan's focus on new energy vehicles amid restructuring offers timely potential opportunities. Click here to explore Nissan's strategic initiatives further. Don't miss our Market Insights article on automation and robotics, where we explored how AI-powered autonomous vehicles are reshaping transportation; dive in now before the trend accelerates further! ended the day at HK$434.20 up 3.3%, near its 52-week high. closed at $10.75 up 0.9%. On Monday, key proposals regarding a collective bargaining policy and supply chain emissions report were not approved at the company's annual shareholder meeting. finished trading at $342.82 down 1.4%. Dive into all 54 of the EV Stocks we have identified, like Honda Motor, Chongqing Qianli Technology and Gentex, right here. Curious About Other Options? We've found 15 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sources: Simply Wall St "Electric Vehicle Charging System Connectivity Market Report 2025-2035: Increasing Demand for Smart and Connected Chargers, Evolution of LTE-M and Its Role in the Future of EV Chargers" from Research and Markets on GlobeNewswire (published 15 May 2025) Companies discussed in this article include TSE:7201 SEHK:1211 NYSE:F NasdaqGS:TSLA and XTRA:BMW. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
